Ahmad Frye
|
 |
Birth control over 30.Among 30-40 year old women, 40% of pregnancies are unplanned, contraceptives which is indicative of the unreliability of the birth control methods they are using. This means that the hormones contained in the tablets are delivered in contraceptives three stages.Each Triphasil cycle of 21 tablets consists of three different drug phases as follows. The 1992 Ortho birth control Study intervie almost 7000 women, of whom 8% listed withdrawal and 4% listed the rhythm method. These two methods have failure rates of 24% and 19%, respectively. Norplant is seasonale a long-term implant containing Levonorgestrel with a failure rate of 0.5%. Barrier methods also offer protection from sexually transmitted diseases including HIV. ortho evra Side effects may include hair drubbing and weight gain; and links to breast cancer have also been suggested.. Birth control methods often disappoint the users and increasingly they turn to sterilization. Pelvic inflammatory disease is the reason. 48% of married women aged 15-44 had themselves been sterilized or had a sterilized partner in the Ortho survey. About half of the women using Norplant removed it after 2.5 years because of irregular bleeding. For women over the age of 30 who are healthy and do not smoke, low-Estrogen jolessa or no-Estrogen oral contraceptive pills are considered safe. Triphasil is a "triphasic" oral contraceptive pill. Diaphragms offer some protection against STDs, but their failure rate is 18%. A 1993 study follo 1253 implant users over 12 months and found a very low rate of pregnancy, but 75% experienced some side effects during the first year. Taking the pill also helps prevent ovarian and endometrial cancer. Although reversal of tubal ligation succeeds in 43-88% of cases, conception cannot be guaranteed. The failure rate is 6%. Phase 1 comprised of 6 brown tablets, each containing 0.050 mg of levonorgestrel, a totally synethic progestogen, and 0.030 mg of ethinyl estradiol; phase 2 comprised of 5 white tablets, each containing 0.075 mg levongestrel and 0.040 mg ethinyl estradiol; phase 3 comprised of 10 light-yellow tablets, each containing 0.125 mg levongestrel and 0.030 mg ethinyl estradiol. Depo-Provera is an injectable administered every 3 months, but after removal it can take up to a year for ovulation to return. IUDs are regaining popularity, but only 1% of women use them (ParaGard T380A or Progestasert). A 1992 study sho that 0.97% of women developed it within 20 days of use. Condoms are favored by 33% of unmarried women and 19% of married women. Sexually active 40-44 term old unmarried women run a 14-19% risk of contracting a sexually transmitted disease (STD) in a 12-month period.
|